Melinda S Schaller1, Joel L Ramirez1, Warren J Gasper2, Greg J Zahner1, Nancy K Hills3, S Marlene Grenon4. 1. Department of Surgery, University of California, San Francisco, San Francisco, CA. 2. Department of Surgery, University of California, San Francisco, San Francisco, CA; Vascular Surgery Section, Veterans Affairs Medical Center, San Francisco, CA. 3. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA. 4. Department of Surgery, University of California, San Francisco, San Francisco, CA; Vascular Surgery Section, Veterans Affairs Medical Center, San Francisco, CA. Electronic address: melinda.schaller@gmail.com.
Abstract
BACKGROUND: Frailty, a syndrome characterized by decreased physiologic reserves and resistance to stressors, is associated with disability, poor surgical outcomes, and mortality. We evaluated the impact of frailty on cardiovascular disease (CVD) events in peripheral arterial disease (PAD) patients with intermittent claudication. METHODS: We conducted a retrospective review of patients with stable intermittent claudication enrolled in the OMEGA-PAD study between 2010 and 2015. The modified frailty index (mFI) is a retrospectively validated index of frailty derived from the Canadian Study of Health and Aging and was used in this study to categorize frailty as low, medium, or high. Our outcome was time to occurrence of a major adverse cardiac event (MACE), defined as a composite endpoint of myocardial infarction, coronary revascularization, stroke, or CVD-related death. Cox proportional hazards models were used to calculate relative hazards ratio. RESULTS: There were 129 subjects with a mean age of 67 years, 97% were men, 36% were diabetic, and 33% had known coronary heart disease. When the mFI criteria were applied, 38 subjects were "low" frailty, 72 were "medium" frailty, and 19 were "high" frailty. During the median follow-up period of 34 months (interquartile range: 25-43), 29 subjects experienced a MACE. When compared to the lowest mFI, patients with medium frailty were 2.8 times more likely to have an event (95% confidence interval [CI]: 0.95-8.46, P = 0.06), whereas patients with a high mFI were 4.8 times as likely (95% CI: 1.43-15.8, P = 0.01). In a model adjusted for age, smoking status, and presence of diabetes, those with a medium mFI were 4.3 times more likely to have an event (95% CI: 1.37-13.7, P = 0.01) and those with a high mFI were 9.2 times as likely (95% CI: 2.6-32.4, P = 0.001). CONCLUSIONS: Higher mFI category is associated with a significantly increased risk of MACE in PAD patients with stable claudication. Frailty may serve as a useful adjunct for assessment of overall cardiac risk, particularly as treatment options are being contemplated.
BACKGROUND: Frailty, a syndrome characterized by decreased physiologic reserves and resistance to stressors, is associated with disability, poor surgical outcomes, and mortality. We evaluated the impact of frailty on cardiovascular disease (CVD) events in peripheral arterial disease (PAD) patients with intermittent claudication. METHODS: We conducted a retrospective review of patients with stable intermittent claudication enrolled in the OMEGA-PAD study between 2010 and 2015. The modified frailty index (mFI) is a retrospectively validated index of frailty derived from the Canadian Study of Health and Aging and was used in this study to categorize frailty as low, medium, or high. Our outcome was time to occurrence of a major adverse cardiac event (MACE), defined as a composite endpoint of myocardial infarction, coronary revascularization, stroke, or CVD-related death. Cox proportional hazards models were used to calculate relative hazards ratio. RESULTS: There were 129 subjects with a mean age of 67 years, 97% were men, 36% were diabetic, and 33% had known coronary heart disease. When the mFI criteria were applied, 38 subjects were "low" frailty, 72 were "medium" frailty, and 19 were "high" frailty. During the median follow-up period of 34 months (interquartile range: 25-43), 29 subjects experienced a MACE. When compared to the lowest mFI, patients with medium frailty were 2.8 times more likely to have an event (95% confidence interval [CI]: 0.95-8.46, P = 0.06), whereas patients with a high mFI were 4.8 times as likely (95% CI: 1.43-15.8, P = 0.01). In a model adjusted for age, smoking status, and presence of diabetes, those with a medium mFI were 4.3 times more likely to have an event (95% CI: 1.37-13.7, P = 0.01) and those with a high mFI were 9.2 times as likely (95% CI: 2.6-32.4, P = 0.001). CONCLUSIONS: Higher mFI category is associated with a significantly increased risk of MACE in PAD patients with stable claudication. Frailty may serve as a useful adjunct for assessment of overall cardiac risk, particularly as treatment options are being contemplated.
Authors: M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner Journal: N Engl J Med Date: 1992-02-06 Impact factor: 91.245
Authors: Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Hugo A Katus; Bertil Lindahl; David A Morrow; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis Journal: Circulation Date: 2012-08-24 Impact factor: 29.690
Authors: Daniel E Hall; Shipra Arya; Kendra K Schmid; Casey Blaser; Mark A Carlson; Travis L Bailey; Georgia Purviance; Tammy Bockman; Thomas G Lynch; Jason Johanning Journal: JAMA Surg Date: 2017-02-01 Impact factor: 14.766
Authors: F Gerry R Fowkes; Victor Aboyans; Freya J I Fowkes; Mary M McDermott; Uchechukwu K A Sampson; Michael H Criqui Journal: Nat Rev Cardiol Date: 2016-11-17 Impact factor: 32.419
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Jay Soong-Jin Lee; Kevin He; Calista M Harbaugh; Douglas E Schaubel; Christopher J Sonnenday; Stewart C Wang; Michael J Englesbe; Jonathan L Eliason Journal: J Vasc Surg Date: 2011-01-07 Impact factor: 4.268
Authors: Mandeep Singh; Karen Alexander; Veronique L Roger; Charanjit S Rihal; Heather E Whitson; Amir Lerman; Arschad Jahangir; K Sreekumaran Nair Journal: Mayo Clin Proc Date: 2008-10 Impact factor: 7.616
Authors: Joseph Karam; Athanasios Tsiouris; Alexander Shepard; Vic Velanovich; Ilan Rubinfeld Journal: Ann Vasc Surg Date: 2013-05-24 Impact factor: 1.466
Authors: Hoi-Ying H Chan; Frank A Segreto; Samantha R Horn; Cole Bortz; Godwin G Choy; Peter G Passias; Hamish H Deverall; Joseph F Baker Journal: Asian Spine J Date: 2019-05-14
Authors: Abdulla A Damluji; Shang-En Chung; Qian-Li Xue; Rani K Hasan; Mauro Moscucci; Daniel E Forman; Karen Bandeen-Roche; Wayne Batchelor; Jeremy D Walston; Jon R Resar; Gary Gerstenblith Journal: Eur Heart J Date: 2021-10-01 Impact factor: 35.855
Authors: Bijan Najafi; Narek Veranyan; Alejandro Zulbaran-Rojas; Catherine Park; Hung Nguyen; Quinn Kaleikaumaka Nakahara; Hector Elizondo-Adamchik; Jayer Chung; Joseph L Mills; Miguel Montero-Baker; David G Armstrong; Vincent Rowe Journal: JAMA Netw Open Date: 2020-11-02